1. Home
  2. GRFS vs PI Comparison

GRFS vs PI Comparison

Compare GRFS & PI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$8.87

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Impinj Inc.

PI

Impinj Inc.

HOLD

Current Price

$163.70

Market Cap

5.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
PI
Founded
1940
2000
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.8B
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
GRFS
PI
Price
$8.87
$163.70
Analyst Decision
Hold
Buy
Analyst Count
2
8
Target Price
$10.15
$222.75
AVG Volume (30 Days)
485.7K
619.6K
Earning Date
07-28-2022
02-05-2026
Dividend Yield
1.60%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$8,821,017,248.00
$359,795,000.00
Revenue This Year
$5.36
$1.30
Revenue Next Year
$5.15
$22.70
P/E Ratio
$17.46
N/A
Revenue Growth
7.31
4.24
52 Week Low
$6.19
$60.85
52 Week High
$11.14
$247.06

Technical Indicators

Market Signals
Indicator
GRFS
PI
Relative Strength Index (RSI) 44.66 41.10
Support Level $8.79 $168.86
Resistance Level $9.40 $215.25
Average True Range (ATR) 0.24 12.30
MACD -0.05 -2.21
Stochastic Oscillator 12.18 3.11

Price Performance

Historical Comparison
GRFS
PI

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About PI Impinj Inc.

Impinj Inc operates a platform that enables wireless connectivity to everyday items by delivering each item's identity, location, and authenticity to business and consumer applications. Its platform includes endpoint integrated circuits (ICs) product, a miniature radios-on-a-chip, which attach to and identify their host items; and connectivity layer that comprises readers, gateways, and reader ICs to wirelessly identify, locate, authenticate, and engage endpoints via RAIN, as well as provide power to and communicate bidirectionally with endpoint ICs. Geographically, the company has a business presence in the Americas, Asia Pacific, Europe, Middle East and Africa, of which key revenue is derived from the operations in the Asia Pacific region.

Share on Social Networks: